|
1
|
Caminati A, Madotto F, Cesana G, Conti S
and Harari S: Epidemiological studies in idiopathic pulmonary
fibrosis: Pitfalls in methodologies and data interpretation. Eur
Respir Rev. 24:436–444. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chanda D, Otoupalova E, Smith SR,
Volckaert T, De Langhe SP and Thannickal VJ: Developmental pathways
in the pathogenesis of lung fibrosis. Mol Aspects Med. 65:56–69.
2019. View Article : Google Scholar :
|
|
3
|
Meyer KC: Pulmonary fibrosis, part I:
Epidemiology, pathogenesis, and diagnosis. Expert Rev Respir Med.
11:343–359. 2017.PubMed/NCBI
|
|
4
|
Johnsson P, Lipovich L, Grandér D and
Morris KV: Evolutionary conservation of long non-coding RNAs;
Sequence, structure, function. Biochim Biophys Acta.
1840:1063–1071. 2014. View Article : Google Scholar
|
|
5
|
Sun C, Huang L, Li Z, Leng K, Xu Y, Jiang
X and Cui Y: Long non-coding RNA MIAT in development and disease: A
new player in an old game. J Biomed Sci. 25:232018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu W, Zhao Y, Gao E, Li Y, Guo X, Zhao T,
He W and Zhang H: LncRNA DLEU2 accelerates the tumorigenesis and
invasion of non-small cell lung cancer by sponging miR-30a-5p. J
Cell Mol Med. 24:441–450. 2020. View Article : Google Scholar
|
|
7
|
Liu W, Liu PC, Ma K, Wang YY, Chi QB and
Yan M: LncRNA DLEU2 promotes tumour growth by sponging miR-337-3p
in human osteosarcoma. Cell Biochem Funct. 38:886–894. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang B, Hang J, Li W and Yuan W: Knockdown
of LncRNA DLEU2 inhibits cervical cancer progression via targeting
miR-128-3p. Onco Targets Ther. 13:10173–10184. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu M, Chen W, Zhuang W and Zhan X:
Label-free quantitative identification of abnormally ubiquitinated
proteins as useful biomarkers for human lung squamous cell
carcinomas. EPMA J. 11:73–94. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao H, Fang Y, Liang Q, Wang J, Luo B,
Zeng G, Zhang T, Jing X and Wang X: TRIM2 is a novel promoter of
human colorectal cancer. Scand J Gastroenterol. 54:210–218. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qin Y, Ye J, Zhao F, Hu S and Wang S:
TRIM2 regulates the development and metastasis of tumorous cells of
osteosarcoma. Int J Oncol. 53:1643–1656. 2018.PubMed/NCBI
|
|
12
|
Dong R, Liu M, Huang XX, Liu Z, Jiang DY,
Xiao HJ, Geng J, Ren YH and Dai HP: Water-Soluble C60
protects against bleomycin-induced pulmonary fibrosis in mice. Int
J Nanomedicine. 15:2269–2276. 2020. View Article : Google Scholar :
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
14
|
Tang F, Li R, Xue J, Lan J, Xu H, Liu Y,
Zhou L and Lu Y: Azithromycin attenuates acute radiation-induced
lung injury in mice. Oncol Lett. 14:5211–5220. 2017.PubMed/NCBI
|
|
15
|
Abdelfattah MS, Elmallah MIY, Ebrahim HY,
Almeer RS, Eltanany RMA and Abdel Moneim AE: Prodigiosins from a
marine sponge-associated actinomycete attenuate HCl/ethanol-induced
gastric lesion via antioxidant and anti-inflammatory mechanisms.
PLoS One. 14:e02167372019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cookson WO and Moffatt MF: Bedside to gene
and back in idiopathic pulmonary fibrosis. N Engl J Med.
368:2228–2230. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fernandez IE and Eickelberg O: New
cellular and molecular mechanisms of lung injury and fibrosis in
idiopathic pulmonary fibrosis. Lancet. 380:680–688. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fell CD, Martinez FJ, Liu LX, Murray S,
Han MK, Kazerooni EA, Gross BH, Myers J, Travis WD, Colby TV, et
al: Clinical predictors of a diagnosis of idiopathic pulmonary
fibrosis. Am J Respir Crit Care Med. 181:832–837. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Baumgart M, Groth M, Priebe S, Savino A,
Testa G, Dix A, Ripa R, Spallotta F, Gaetano C, Ori M, et al:
RNA-seq of the aging brain in the short-lived fish N.
furzeri-conserved pathways and novel genes associated with
neurogenesis. Aging Cell. 13:965–974. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Benayoun BA, Pollina EA and Brunet A:
Epigenetic regulation of ageing: Linking environmental inputs to
genomic stability. Nat Rev Mol Cell Biol. 16:593–610. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Grammatikakis I, Panda AC, Abdelmohsen K
and Gorospe M: Long noncoding RNAs(lncRNAs) and the molecular
hallmarks of aging. Aging (Albany NY). 6:992–1009. 2014. View Article : Google Scholar
|
|
22
|
Huang C, Yang Y and Liu L: Interaction of
long noncoding RNAs and microRNAs in the pathogenesis of idiopathic
pulmonary fibrosis. Physiol Genomics. 47:463–469. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xie Z, Li X, Chen H, Zeng A, Shi Y and
Tang Y: The lncRNA-DLEU2/miR-186-5p/PDK3 axis promotes the progress
of glioma cells. Am J Transl Res. 11:4922–4934. 2019.PubMed/NCBI
|
|
24
|
Guo Y, Bai M, Lin L, Huang J, An Y, Liang
L, Liu Y and Huang W: LncRNA DLEU2 aggravates the progression of
hepatocellular carcinoma through binding. Biomed Pharmacother.
118:1092722019. View Article : Google Scholar
|
|
25
|
Lu T, Wang R, Cai H and Cui Y: Long
non-coding RNA DLEU2 promotes the progression of esophageal cancer
through miR-30e-5p/E2F7 axis. Biomed Pharmacother. 123:1096502020.
View Article : Google Scholar
|
|
26
|
Li C, Wang Z, Zhang J, Zhao X, Xu P, Liu
X, Li M, Lv C and Song X: Crosstalk of mRNA, miRNA, lncRNA, and
circRNA and their regulatory pattern in pulmonary fibrosis. Mol
Ther Nucleic Acids. 18:204–218. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu P, Ma C, Wu Q, Zhang W, Wang C, Yuan L
and Xi X: MiR-369-3p participates in endometrioid adenocarcinoma
via the regulation of autophagy. Cancer Cell Int. 19:1782019.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pan W, Yu H, Zheng B, Gao Y, Li P, Huang
Q, Xie C and Ge X: Upregulation of MiR-369-3p suppresses cell
migration and proliferation by targeting SOX4 in Hirschsprung's
disease. J Pediatr Surg. 52:1363–1370. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu Q and Liu K: MiR-369-3p inhibits
tumorigenesis of hepatocellular carcinoma by binding to PAX6. J
Biol Regul Homeost Agents. 34:917–926. 2020.PubMed/NCBI
|
|
30
|
Scalavino V, Liso M, Cavalcanti E, Gigante
I, Lippolis A, Mastronardi M, Chieppa M and Serino G: miR-369-3p
modulates inducible nitric oxide synthase and is involved in
regulation of chronic inflammatory response. Sci Rep. 10:159422020.
View Article : Google Scholar : PubMed/NCBI
|
